Teva files initial beneficial ownership statement for director David J. Brailer
TEVA•Teva director David J. Brailer filed an initial beneficial ownership statement signed Nov. 12, 2026.
1. Ownership filing
David J. Brailer, a director of Teva Pharmaceutical, filed an initial statement of beneficial ownership signed Nov. 12, 2026.
